Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis

Area of Science:

• Neuroscience
• Biochemistry
• Epidemiology

Background:

• High serum/plasma cholesterol is a proposed Alzheimer's disease (AD) risk factor.
• Retrospective studies suggest statins may decrease AD prevalence.
• Experimental data links cholesterol levels to amyloid precursor protein (APP) and amyloid beta-protein (Ab).

Purpose of the Study:

• To critically evaluate the cholesterol-AD hypothesis.
• To discuss the involvement of other lipids in the mevalonate pathway.
• To consider AD's impact on cholesterol homeostasis.

Main Methods:

• Review of epidemiological and experimental studies.
• Analysis of conflicting evidence regarding cholesterol and AD.
• Examination of statin efficacy in AD prevention/treatment.

Main Results:

• Serum/plasma and brain cholesterol levels in AD patients do not consistently support a causative role.
• Prospective studies on statins largely show no significant efficacy in AD.
• Experimental data linking cholesterol to APP/Ab is complex and open to interpretation.

Conclusions:

• The direct causative role of cholesterol in AD remains uncertain.
• Evidence supporting the cholesterol-AD hypothesis is conflicting.
• Further research is needed to clarify the role of lipids in AD pathogenesis.